Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1950 1
1962 1
1972 1
1983 2
1987 1
1991 1
1994 2
1995 1
1996 5
1997 4
1998 4
1999 2
2000 5
2001 5
2002 4
2003 7
2004 11
2005 5
2006 12
2007 13
2008 12
2009 8
2010 15
2011 14
2012 16
2013 17
2014 13
2015 17
2016 20
2017 10
2018 14
2019 11
2020 14
2021 10
2022 13
2023 10
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

262 results

Results by year

Filters applied: . Clear all
Page 1
EBV-driven lymphoid neoplasms associated with pediatric ALL maintenance therapy.
Elitzur S, Vora A, Burkhardt B, Inaba H, Attarbaschi A, Baruchel A, Escherich G, Gibson B, Liu HC, Loh M, Moorman AV, Möricke A, Pieters R, Uyttebroeck A, Baird S, Bartram J, Barzilai-Birenboim S, Batra S, Ben-Harosh M, Bertrand Y, Buitenkamp T, Caldwell K, Drut R, Geerlinks AV, Gilad G, Grainger J, Haouy S, Heaney N, Huang M, Ingham D, Krenova Z, Kuhlen M, Lehrnbecher T, Manabe A, Niggli F, Paris C, Revel-Vilk S, Rohrlich P, Sinno MG, Szczepanski T, Tamesberger M, Warrier R, Wolfl M, Nirel R, Izraeli S, Borkhardt A, Schmiegelow K. Elitzur S, et al. Among authors: niggli f. Blood. 2023 Feb 16;141(7):743-755. doi: 10.1182/blood.2022016975. Blood. 2023. PMID: 36332176 Free article.
Invasive fungal diseases impact on outcome of childhood ALL - an analysis of the international trial AIEOP-BFM ALL 2009.
Lehrnbecher T, Groll AH, Cesaro S, Alten J, Attarbaschi A, Barbaric D, Bodmer N, Conter V, Izraeli S, Mann G, Möricke A, Niggli F, Schrappe M, Stary J, Zapotocka E, Zimmermann M, Elitzur S. Lehrnbecher T, et al. Among authors: niggli f. Leukemia. 2023 Jan;37(1):72-78. doi: 10.1038/s41375-022-01768-x. Epub 2022 Dec 12. Leukemia. 2023. PMID: 36509893 Free PMC article. Clinical Trial.
Incidence and Characteristics of Hypersensitivity Reactions to PEG-asparaginase Observed in 6136 Children With Acute Lymphoblastic Leukemia Enrolled in the AIEOP-BFM ALL 2009 Study Protocol.
Rizzari C, Möricke A, Valsecchi MG, Conter V, Zimmermann M, Silvestri D, Attarbaschi A, Niggli F, Barbaric D, Stary J, Elitzur S, Cario G, Vinti L, Boos J, Zucchetti M, Lanvers-Kaminsky C, von Stackelberg A, Biondi A, Schrappe M. Rizzari C, et al. Among authors: niggli f. Hemasphere. 2023 Jun 1;7(6):e893. doi: 10.1097/HS9.0000000000000893. eCollection 2023 Jun. Hemasphere. 2023. PMID: 37275740 Free PMC article.
Effect of two additional doses of intrathecal methotrexate during induction therapy on serious infectious toxicity in pediatric patients with acute lymphoblastic leukemia.
Heilmann J, Vieth S, Möricke A, Attarbaschi A, Barbaric D, Bodmer N, Colombini A, Dalla-Pozza L, Elitzur S, Izraeli S, Mann G, Niggli F, Silvestri D, Stary J, Rizzari C, Valsecchi MG, Zapotocka E, Zimmermann M, Cario G, Schrappe M, Conter V. Heilmann J, et al. Among authors: niggli f. Haematologica. 2023 Dec 1;108(12):3278-3286. doi: 10.3324/haematol.2022.281788. Haematologica. 2023. PMID: 37021527 Free PMC article.
Four Additional Doses of PEG-L-Asparaginase During the Consolidation Phase in the AIEOP-BFM ALL 2009 Protocol Do Not Improve Outcome and Increase Toxicity in High-Risk ALL: Results of a Randomized Study.
Conter V, Valsecchi MG, Cario G, Zimmermann M, Attarbaschi A, Stary J, Niggli F, Dalla Pozza L, Elitzur S, Silvestri D, Locatelli F, Möricke A, Engstler G, Smisek P, Bodmer N, Barbaric D, Izraeli S, Rizzari C, Boos J, Buldini B, Zucchetti M, von Stackelberg A, Matteo C, Lehrnbecher T, Lanvers-Kaminsky C, Cazzaniga G, Gruhn B, Biondi A, Schrappe M. Conter V, et al. Among authors: niggli f. J Clin Oncol. 2024 Mar 10;42(8):915-926. doi: 10.1200/JCO.23.01388. Epub 2023 Dec 14. J Clin Oncol. 2024. PMID: 38096462
Port-A-Cath infections in children with cancer.
Hengartner H, Berger C, Nadal D, Niggli FK, Grotzer MA. Hengartner H, et al. Among authors: niggli fk. Eur J Cancer. 2004 Nov;40(16):2452-8. doi: 10.1016/j.ejca.2004.07.017. Eur J Cancer. 2004. PMID: 15519519 Review.
USP19 deubiquitinates EWS-FLI1 to regulate Ewing sarcoma growth.
Gierisch ME, Pedot G, Walser F, Lopez-Garcia LA, Jaaks P, Niggli FK, Schäfer BW. Gierisch ME, et al. Among authors: niggli fk. Sci Rep. 2019 Jan 30;9(1):951. doi: 10.1038/s41598-018-37264-5. Sci Rep. 2019. PMID: 30700749 Free PMC article.
The role of Epstein-Barr virus in Hodgkin's disease from different geographical areas.
Weinreb M, Day PJ, Niggli F, Powell JE, Raafat F, Hesseling PB, Schneider JW, Hartley PS, Tzortzatou-Stathopoulou F, Khalek ER, Mangoud A, El-Safy UR, Madanat F, Al Sheyyab M, Mpofu C, Revesz T, Rafii R, Tiedemann K, Waters KD, Barrantes JC, Nyongo A, Riyat MS, Mann JR. Weinreb M, et al. Among authors: niggli f. Arch Dis Child. 1996 Jan;74(1):27-31. doi: 10.1136/adc.74.1.27. Arch Dis Child. 1996. PMID: 8660041 Free PMC article. Review.
262 results